Tuesday, December 16, 2014 2:42:08 PM
Doc 186 PDF file
https://www.scribd.com/doc/250313132/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-186-Filed-15-Dec-14
Extract -
At this time, the SEC is unable to apprise the Court as to Defendant Jean-François Amyot’s position on this motion. Since the morning of November 17, 2014, Amyot has not responded to any telephone calls or e-mail communications from counsel to the SEC. As required by the Local Rules, undersigned counsel attempted to contact Amyot via e-mail shortly after 9:00 am this morning to meet and confer regarding this motion to adjourn, but as of 4:00 pm today, Amyot had not responded.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM